SpyGlass Pharma (SGP) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on SpyGlass Pharma (SGP) is Moderate Underperform.

The composite score behind that read is -0.39, weighing +0.00 of bullish evidence against -0.38 bearish.

SpyGlass Pharma last closed at $25.59, +2.69% on the session.

Against the IVW growth benchmark the position is +1.77% over the forecast window.

The read is built from 12 underlying insights — 0 bullish and 12 bearish.

Agreement across those insights is 100%.

16 graded predictions for SGP so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks SpyGlass Pharma in the 14th percentile on return on equity, where 100 is best.

SpyGlass Pharma is classified under Health Care / Pharmaceuticals, with a market capitalisation of $833.52M.

StockMap tracks SpyGlass Pharma as the 57th largest of the 128 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 54 Moderate Underperform, 53 Neutral, 15 Strong Underperform and 6 Moderate Outperform.

On that composite SpyGlass Pharma ranks 94th of 128 in the group, against a group median of -0.24.